Jamjoom Pharmaceuticals Factory Co.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SA15QGU1UNH6
SAR
137.50
-3.3 (-2.34%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
1,318.48
1,100.82
916.67
735.68
805.31
731.73
701.30
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,318.48
1,100.82
916.67
735.68
805.31
731.73
701.30
Raw Material Cost
505.97
404.81
329.93
267.94
331.06
312.30
263.01
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
296.32
254.02
233.08
197.84
183.58
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.67
0.63
0.86
3.18
0.00
0.00
5.22
Selling and Distribution Expenses
394.92
348.47
324.71
248.98
234.34
244.89
266.42
Other Expenses
-26.53
-22.36
-20.37
-16.66
-18.36
0.00
-0.52
Total Expenditure (Excl Depreciation)
932.55
784.34
684.85
551.38
565.40
557.19
529.43
Operating Profit (PBDIT) excl Other Income
385.90000000000003
316.5
231.8
184.3
239.89999999999998
174.5
171.9
Other Income
-5.44
1.40
-43.09
8.06
2.82
1.13
-0.42
Operating Profit (PBDIT)
412.51
344.50
213.46
216.72
285.23
218.22
213.91
Interest
0.67
0.63
0.86
3.18
0.00
0.00
5.22
Exceptional Items
-10.34
-5.85
-1.24
-1.04
-10.42
0.00
0.00
Gross Profit (PBDT)
812.51
696.01
586.74
467.74
474.25
419.43
438.29
Depreciation
37.42
26.63
24.73
24.35
42.49
42.55
42.46
Profit Before Tax
364.08
311.39
186.63
188.14
232.31
175.67
166.23
Tax
26.13
23.40
15.00
17.39
24.88
18.74
15.40
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
356.52
292.40
171.31
170.70
206.86
156.93
150.84
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
356.52
292.40
171.31
170.70
206.86
156.93
150.84
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
356.52
292.40
171.31
170.70
206.86
156.93
150.84
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
1,490.61
1,404.33
1,216.26
1,231.64
1,179.07
1,069.52
999.77
Earnings per share (EPS)
5.09
4.18
2.45
2.44
2.96
2.24
2.15
Diluted Earnings per share
5.09
4.18
2.45
2.44
2.96
2.24
2.15
Operating Profit Margin (Excl OI)
28.86%
28.75%
25.29%
25.05%
29.79%
23.85%
24.51%
Gross Profit Margin
30.45%
30.71%
23.06%
28.88%
34.12%
29.82%
29.76%
PAT Margin
27.04%
26.56%
18.69%
23.2%
25.69%
21.45%
21.51%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 19.78% vs 20.08% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 21.92% vs 70.69% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 21.83% vs 33.71% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 16.67% vs -33.33% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Jamjoom Pharmaceuticals Factory Co. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(SAR)
Change(%)
Net Sales
1,318.48
0
1,318.48
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,318.48
0
1,318.48
Raw Material Cost
505.97
0
505.97
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
296.32
0
296.32
Power Cost
0
0
0.00
Manufacturing Expenses
0.67
0
0.67
Selling and Distribution Expenses
394.92
0
394.92
Other Expenses
-26.53
0.00
-26.53
Total Expenditure (Excl Depreciation)
932.55
0
932.55
Operating Profit (PBDIT) excl Other Income
385.92
0.00
385.92
Other Income
-5.44
0
-5.44
Operating Profit (PBDIT)
412.51
0
412.51
Interest
0.67
0
0.67
Exceptional Items
-10.34
0
-10.34
Gross Profit (PBDT)
812.51
0
812.51
Depreciation
37.42
0
37.42
Profit Before Tax
364.08
0
364.08
Tax
26.13
0
26.13
Provisions and contingencies
0
0
0.00
Profit After Tax
356.52
0
356.52
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
356.52
0
356.52
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
356.52
0
356.52
Equity Capital
0
0
0.00
Face Value
10.00
0
0.00
Reserves
1,490.61
0
1,490.61
Earnings per share (EPS)
5.09
0
5.09
Diluted Earnings per share
5.09
0
5.09
Operating Profit Margin (Excl OI)
28.86%
0%
0.00
28.86%
Gross Profit Margin
30.45%
0%
0.00
30.45%
PAT Margin
27.04%
0%
0.00
27.04%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 131.85 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 19.78% vs 20.08% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 35.65 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 21.92% vs 70.69% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 41.80 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 21.83% vs 33.71% in Dec 2023

Annual - Interest
Interest 0.07 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 16.67% vs -33.33% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 28.86%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023